Bulwark Capital’s Boston Scientific BSX Stock Holding History

Bulwark Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.73K	Buy	+200	New	+$9.26K	﹤0.01%	97

Other funds holding BSX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Bulwark Capital's BSX Position: Q3 2026 in Review

Bulwark Capital opened a new position in Boston Scientific (BSX) in Q3 2026: 200 shares worth $8.73K. The stake represents ﹤0.01% of the portfolio and ranks #97 among its holdings.

1,117 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Bulwark Capital held 200 shares of Boston Scientific worth $8.73K as of Q3 2026.
Boston Scientific was a new Bulwark Capital position in Q3 2026.
Boston Scientific made up ﹤0.01% of Bulwark Capital's portfolio in Q3 2026, its #97 holding.
1,117 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Bulwark Capital's 13F filing for Q3 2026, filed 13 Oct 2026.